S&P 500   3,354.55 (+0.10%)
DOW   27,704.82 (+0.99%)
QQQ   268.25 (-1.19%)
AAPL   449.18 (+1.06%)
MSFT   207.18 (-2.49%)
FB   263.60 (-1.80%)
GOOGL   1,490.47 (-0.53%)
AMZN   3,130.01 (-1.18%)
NVDA   445.47 (-0.56%)
CGC   18.01 (+8.30%)
BABA   247.34 (-1.89%)
TSLA   1,412.60 (-2.76%)
MU   49.09 (+0.70%)
GE   6.62 (+3.44%)
AMD   81.23 (-4.27%)
T   30.09 (+0.23%)
F   7.12 (+3.64%)
ACB   10.19 (-0.78%)
GILD   68.15 (-1.73%)
NFLX   483.88 (-2.19%)
DIS   129.46 (-0.36%)
BAC   26.58 (+1.80%)
BA   177.61 (+4.46%)
S&P 500   3,354.55 (+0.10%)
DOW   27,704.82 (+0.99%)
QQQ   268.25 (-1.19%)
AAPL   449.18 (+1.06%)
MSFT   207.18 (-2.49%)
FB   263.60 (-1.80%)
GOOGL   1,490.47 (-0.53%)
AMZN   3,130.01 (-1.18%)
NVDA   445.47 (-0.56%)
CGC   18.01 (+8.30%)
BABA   247.34 (-1.89%)
TSLA   1,412.60 (-2.76%)
MU   49.09 (+0.70%)
GE   6.62 (+3.44%)
AMD   81.23 (-4.27%)
T   30.09 (+0.23%)
F   7.12 (+3.64%)
ACB   10.19 (-0.78%)
GILD   68.15 (-1.73%)
NFLX   483.88 (-2.19%)
DIS   129.46 (-0.36%)
BAC   26.58 (+1.80%)
BA   177.61 (+4.46%)
S&P 500   3,354.55 (+0.10%)
DOW   27,704.82 (+0.99%)
QQQ   268.25 (-1.19%)
AAPL   449.18 (+1.06%)
MSFT   207.18 (-2.49%)
FB   263.60 (-1.80%)
GOOGL   1,490.47 (-0.53%)
AMZN   3,130.01 (-1.18%)
NVDA   445.47 (-0.56%)
CGC   18.01 (+8.30%)
BABA   247.34 (-1.89%)
TSLA   1,412.60 (-2.76%)
MU   49.09 (+0.70%)
GE   6.62 (+3.44%)
AMD   81.23 (-4.27%)
T   30.09 (+0.23%)
F   7.12 (+3.64%)
ACB   10.19 (-0.78%)
GILD   68.15 (-1.73%)
NFLX   483.88 (-2.19%)
DIS   129.46 (-0.36%)
BAC   26.58 (+1.80%)
BA   177.61 (+4.46%)
S&P 500   3,354.55 (+0.10%)
DOW   27,704.82 (+0.99%)
QQQ   268.25 (-1.19%)
AAPL   449.18 (+1.06%)
MSFT   207.18 (-2.49%)
FB   263.60 (-1.80%)
GOOGL   1,490.47 (-0.53%)
AMZN   3,130.01 (-1.18%)
NVDA   445.47 (-0.56%)
CGC   18.01 (+8.30%)
BABA   247.34 (-1.89%)
TSLA   1,412.60 (-2.76%)
MU   49.09 (+0.70%)
GE   6.62 (+3.44%)
AMD   81.23 (-4.27%)
T   30.09 (+0.23%)
F   7.12 (+3.64%)
ACB   10.19 (-0.78%)
GILD   68.15 (-1.73%)
NFLX   483.88 (-2.19%)
DIS   129.46 (-0.36%)
BAC   26.58 (+1.80%)
BA   177.61 (+4.46%)
Log in

NASDAQ:RWLKRewalk Robotics Stock Price, Forecast & News

$1.31
+0.02 (+1.55 %)
(As of 08/10/2020 12:03 PM ET)
Add
Compare
Today's Range
$1.31
Now: $1.31
$1.32
50-Day Range
$1.19
MA: $1.43
$1.88
52-Week Range
$0.41
Now: $1.31
$3.89
Volume480 shs
Average Volume1.46 million shs
Market Capitalization$25.07 million
P/E RatioN/A
Dividend YieldN/A
Beta3.63
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Read More
Rewalk Robotics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:RWLK
CUSIPN/A
Phone972-4959-0123

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.87 million
Book Value$1.48 per share

Profitability

Net Income$-15,550,000.00
Net Margins-379.84%

Miscellaneous

Employees58
Market Cap$25.07 million
Next Earnings Date8/12/2020 (Confirmed)
OptionableNot Optionable
$1.31
+0.02 (+1.55 %)
(As of 08/10/2020 12:03 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RWLK News and Ratings via Email

Sign-up to receive the latest news and ratings for RWLK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions

How has Rewalk Robotics' stock been impacted by COVID-19 (Coronavirus)?

Rewalk Robotics' stock was trading at $0.6050 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RWLK shares have increased by 116.5% and is now trading at $1.31.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Rewalk Robotics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Rewalk Robotics
.

When is Rewalk Robotics' next earnings date?

Rewalk Robotics is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020.
View our earnings forecast for Rewalk Robotics
.

How can I listen to Rewalk Robotics' earnings call?

Rewalk Robotics will be holding an earnings conference call on Wednesday, August 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Rewalk Robotics' earnings last quarter?

Rewalk Robotics Ltd (NASDAQ:RWLK) issued its quarterly earnings data on Thursday, May, 28th. The medical device company reported ($0.37) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.11. The medical device company had revenue of $0.76 million for the quarter, compared to analysts' expectations of $2.20 million. Rewalk Robotics had a negative return on equity of 111.44% and a negative net margin of 379.84%.
View Rewalk Robotics' earnings history
.

What price target have analysts set for RWLK?

1 brokerages have issued 12 month price objectives for Rewalk Robotics' shares. Their forecasts range from $3.50 to $3.50. On average, they anticipate Rewalk Robotics' share price to reach $3.50 in the next year. This suggests a possible upside of 167.2% from the stock's current price.
View analysts' price targets for Rewalk Robotics
.

Has Rewalk Robotics been receiving favorable news coverage?

News coverage about RWLK stock has been trending very positive this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rewalk Robotics earned a news sentiment score of 3.2 on InfoTrie's scale. They also gave media stories about the medical device company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Rewalk Robotics
.

Who are some of Rewalk Robotics' key competitors?

What other stocks do shareholders of Rewalk Robotics own?

Who are Rewalk Robotics' key executives?

Rewalk Robotics' management team includes the following people:
  • Mr. Lawrence J. Jasinski, CEO & Director (Age 62)
  • Mr. Ori Gon, Chief Financial Officer (Age 38)
  • Ms. Miri Pariente, VP of QA & Operations (Age 42)
  • Mr. Loren Wass, VP of Sales & Reimbursement
  • Mr. Andy Dolan, VP of Marketing

What is Rewalk Robotics' stock symbol?

Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

Who are Rewalk Robotics' major shareholders?

Rewalk Robotics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.37%). Company insiders that own Rewalk Robotics stock include Lawrence J Jasinski and Ofir Koren.
View institutional ownership trends for Rewalk Robotics
.

Which major investors are buying Rewalk Robotics stock?

RWLK stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC.
View insider buying and selling activity for Rewalk Robotics
.

How do I buy shares of Rewalk Robotics?

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rewalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $1.31.

How big of a company is Rewalk Robotics?

Rewalk Robotics has a market capitalization of $25.07 million and generates $4.87 million in revenue each year. The medical device company earns $-15,550,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.

What is Rewalk Robotics' official website?

The official website for Rewalk Robotics is www.rewalk.com.

How can I contact Rewalk Robotics?

Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.